Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Preferred Stock Liabilities (2020 - 2021)

Rapid Micro Biosystems' Preferred Stock Liabilities history spans 2 years, with the latest figure at $235.8 million for Q2 2021.

  • For Q2 2021, Preferred Stock Liabilities rose 60.1% year-over-year to $235.8 million; the TTM value through Jun 2021 reached $235.8 million, up 60.1%, while the annual FY2020 figure was $151.8 million, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q2 2021 was $235.8 million at Rapid Micro Biosystems, up from $233.8 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $235.8 million in Q2 2021 and bottomed at $147.3 million in Q2 2020.